Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 42Lymphoma 37Lymphoma, Mantle-Cell 35Lymphoma, Non-Hodgkin 32Multiple Myeloma 30Lymphoma, Follicular 30Hodgkin Disease 23Recurrence 19Lymphoma, Large B-Cell, Diffuse 19Lymphoma, B-Cell, Marginal Zone 18Waldenstrom Macroglobulinemia 12Leukemia 11Precursor Cell Lymphoblastic Leukemia-Lymphoma 10Lymphoma, B-Cell 9Neoplasms, Plasma Cell 7Lymphoma, T-Cell 6Leukemia, Myeloid, Acute 6Burkitt Lymphoma 6Myelodysplastic Syndromes 5Leukemia, B-Cell 5Hematologic Neoplasms 5Sezary Syndrome 4Neoplasms 4Mycosis Fungoides 4Immune System Diseases 4Small Cell Lung Carcinoma 3Neoplasm Metastasis 3Myeloproliferative Disorders 3Lymphoma, T-Cell, Peripheral 3Lymphoma, T-Cell, Cutaneous 3

Interventions

Rocuronium 2Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 2ziprasidone 1venetoclax 1saponin QA-21V1 1perflutren 1finerenone 1empagliflozin 1Zolpidem 1Warfarin 1Vecuronium Bromide 1Vancomycin 1Tranexamic Acid 1Tobramycin 1Thalidomide 1Surveys and Questionnaires 1Stem Cell Transplantation 1Spironolactone 1Specimen Handling 1Simethicone 1Sevelamer 1Resistance Training 1Quillaja Saponins 1Protein Subunit Vaccines 1Polymorphism, Genetic 1Piperacillin, Tazobactam Drug Combination 1Phlebotomy 1Pentobarbital 1Oxycodone 1Nifedipine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Renal Insufficiency, Chronic × Bendamustine Hydrochloride × Clear all
NCT02424851 2022-01-27

OPTIMAL

Oxford University Hospitals NHS Trust

Phase 2 Completed
31 enrolled 13 charts
Plasma cell

Multiple Myeloma, Renal Insufficiency, Chronic, Renal Insufficiency, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡